Evidence map›Paper›PMID 28874369›Full record

ArticleAntimicrobial agents and chemotherapy2017

Transcriptional and Mutational Profiling of an Aminoglycoside-Resistant Pseudomonas aeruginosa Small-Colony Variant.

Monika Schniederjans, Michal Koska, Susanne Häussler

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Potential in-host evolution ofMicrobiology spectrum · 2025
    Article
  3. Article
  4. Glutamate potentiates susceptibility ofFrontiers in microbiology · 2025
    Article
  5. Review
  6. Article
  7. Mutation toAntimicrobial agents and chemotherapy · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Novel Molecular Markers Linked toAntibiotics (Basel, Switzerland) · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Monika SchniederjansDepartment of Molecular Bacteriology, Helmholtz Center for Infection Research, Braunschweig, Germany.
Michal KoskaCenter for Clinical and Experimental Infection Research, Institute for Molecular Bacteriology, TWINCORE GmbH, Hannover, Germany.
Susanne HäusslerDepartment of Molecular Bacteriology, Helmholtz Center for Infection Research, Braunschweig, Germany susanne.haeussler@helmholtz-hzi.de.
Center for Experimental and Clinical Infection Research · DEHelmholtz Centre for Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MutationAminoglycosidesAnti-Bacterial AgentsBacterial ProteinsDrug Resistance, BacterialGene Expression Regulation, BacterialHumansPhenotypePseudomonas aeruginosaTobramycinAminoglycosidesAnti-Bacterial AgentsBacterial ProteinspmrA protein, BacteriaTobramycinantibiotic resistancePseudomonas aeruginosasmall-colony varianttwo-component systems

Identifiers

PMID28874369
PMCPMC5655060
OpenAlexW2750641521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.